Thyroid Neoplasia: Evolving Algorithms of Diagnosis and Treatment in the Age of Molecular Theranostics

This Content is only for members, Please login to view.

Joint Providership Accreditation Statement:
Must Read: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the College of American Pathologists and the New York Pathological Society. The College of American Pathologists is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:
Must Read: The College of American Pathologists designates this live educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclaimer:
Must Read: The content of this CME activity does not necessarily reflect the view or policies of the College of American Pathologists.

Learning Objectives:

1)Learners will be able to distinguish subtypes of carcinomas by molecular signature in addition to morphology.

2) Learners will understand the important parameters to document in surgical pathology reports with insight into how the documented information will impact clinical care.

3) Learners will learn to actively engage with the clinical colleagues in order to effect and collaborate on patient care plans and suggest/understand care planning based upon a deeper knowledge tumor biology.

Organizer(s):

Isabel Fiel, MD – President
Nada Farhat, MD – Vice President
Peter Sadow, MD- Speaker